• 대한약침학회지
• /
• 제25권3호
• /
• pp.290-300
• /
• 2022

Objectives: This study was conducted to evaluate the safety of SU-Eohyeol pharmacopuncture (SUEP) by assessing its potential to cause chromosomal abnormalities in Chinese hamster lung cells (CHL/IC). Methods: A dose-curve was conducted to determine the highest dose of SUEP. Doses of 10, 5, 2.5, 1.25, 0.625, and 0.313% were used, and no cytotoxicity or SUEP precipitation was observed. SUEP doses of 10, 5, and 2.5%, with positive and negative controls, were used in a chromosome aberration test. Results: In this study, the frequency of abnormal chromosomal cells in the SUEP group did not show a statistically significant difference from that of the negative control group in short-term treatments with and without metabolic activation and the continuous treatment without metabolic activation. Compared with the negative control group, the positive control group had a significantly higher frequency of cells with structural chromosomal abnormalities. This test's results satisfied all conditions for determining the results. Conclusion: SUEP did not induce chromosomal aberrations under the conditions of this study. Other toxicity evaluations, safety studies in humans, and various clinical trials are required to evaluate the safety and efficacy of SUEP.

• Clinical and Experimental Reproductive Medicine
• /
• 제50권3호
• /
• pp.192-199
• /
• 2023

Objective: This study was conducted to investigate chromosomal abnormalities and their correlations with clinical and radiological findings in females with primary amenorrhea (PA). Methods: Detailed forms were recorded for 470 females, including the construction of three-generation pedigrees. Peripheral venous blood was drawn, with informed consent, for cytogenetic analysis. Results: An abnormal karyotype was found in 16.38% of participants. The incidence of structural abnormalities (6.8%) exceeded that of numerical abnormalities (6.15%). Turner syndrome represented 45% of all numerical abnormalities. Furthermore, the Y chromosome was detected in 5% of females with PA. Among the structural chromosomal abnormalities detected (n=32) were mosaicism (25%), deletions (12.5%), isochromosomes (18.75%), fragile sites (3.12%), derivatives (3.12%), marker chromosomes (3.12%), and normal variants (29.125%). An examination of secondary sexual characteristics revealed that 29.6% of females had a complete absence of breast development, 29.78% lacked pubic hair, and 36.88% exhibited no axillary hair development. Radiological findings revealed that 51.22% of females had a hypoplastic uterus and 26.66% had a completely absent uterus. Abnormal ovarian development, such as the complete absence of both ovaries, absence of one ovary, one absent and other streak, or both streak ovaries, was observed in 69.47% of females with PA. Additionally 43.1%, 36.1%, 67.4%, and 8% of females had elevated levels of serum follicle-stimulating hormone, luteinizing hormone, thyroid-stimulating hormone, and prolactin, respectively. Conclusion: This study underscores the importance of karyotyping as a fundamental diagnostic tool for assessing PA. The cytogenetic correlation with these profiles will aid in genetic counseling and further management of the condition.

• 대한한의학방제학회지
• /
• 제20권1호
• /
• pp.13-24
• /
• 2012

Objectives : Yukmijihwang-tang(Wan), a well-known formula for invigorating yin-particular kidney yin, was first recorded in "Xiao er Yao Zheng Zhi Jue", consisting of Radix Rehmanniae Preparata, Fructus Macrocarpii, Rhizoma Dioscoreae Oppositae, Poria, Rhizoma Alismatis and Cortex Moutan Radicis with dose proportion of 8:4:4:3:3:3. Although clinical trials have been lacking, various pharmacological actions for Yukmijihwang-tang has been identified newly using animal models. In addition, it was reported that Yukmijihwang-tang increases structural chromosome aberrations significantly in Chinese hamster lung cells. In this article, it is purposed that new studies for pharmacology and toxicology of Yukmijihwang-tang are reviewed. Insight into new studies of Yukmijihwang-tang at the cellular and animal levels will enhance our understanding of Yukmijihwang-tang against various diseases will provide new tools to diagnose and treat patients. Methods : Recent researches for Yukmijihwang-tang were reviewed and summarized in terms of pharmacological action and toxicity. All sources for review were based on recent studies loaded on data base of web sites such as Science Direct and National Center for Biotechnology Information. Results and Conclusions : Recently, reports showed that YMJ had antiaging effects, antioxidant and free radical scavenging activities, anti-renal hypertension and prevented tumors, and diabetes mellitus. However, there is little information on its safety except general toxicity, acute and sub-chronic oral toxicity, or genotoxicity. In addition, clinical trial for Yukmijihwang-tang was limited even though Yukmijihwang-tang has been used extensively in Korean traditional medicine. Thus, further studies are necessary to focus on safety evaluation and clinical trial for Yukmijihwang-tang.

• 대한본초학회지
• /
• 제22권4호
• /
• pp.287-300
• /
• 2007

Objectives : The genotoxicity of extract of "Hyeonggaeyeongyotang", a polyherbal formula has been used as a tonic agents in oriental medicine was tested. Methods : Extract of "Hyeonggaeyeongyotang" was tested by In Vitro Chromosome Aberration Test, Bacterial Reverse Mutation Assay and Micronucleus test according to OECD Guidelines and KFDA Guidelines [2005-60]. Results : The obtained results were as follows: 1. Chromosome Aberration Test: No significant changes in the number of aberrant metaphases having structural and number of aberrations were detected in all concentrations of "Hyeonggaeyeongyotang" extracts treated in this study. 2. Bacterial Reverse Mutation Assay: No significant increases in the number of revertant colonies compared to its negative control were detected in all concentrations of "Hyeonggaeyeongyotang" extracts treated in this study against all 5 strains except for $50{\mu}g/ml$ treated group where significantly decreases in colony numbers were detected agains all five strains used in this study as pharmacological effects not genotoxicity. 3. Micronucleus test: No significant changes in the number of micronucleated polychromatic erythrocytes among 2000 polychromatic erythrocytes compared to negative control were detected in all "Hyeonggaeyeongyotang" extracts-dosing groups tested. Conclusions : From above-mentioned results, it is concluded that "Hyeonggaeyeongyotang" extracts have not any genotoxicity against In Vitro Chromosome Aberration Test, Bacterial Reverse Mutation Assay and Micronucleus test.

• Toxicological Research
• /
• 제24권4호
• /
• pp.321-328
• /
• 2008

Smoke flavors based on the thermal decomposition of wood have been applied to a variety of food products as an alternative for traditional smoking. Despite its increasing use, the available genotoxicity data on wood smoke flavors (WSF) are still controversial. Thus, potential genotoxic effects of WSF in four short-term in vitro genotoxicity assays were investigated, which included the Ames assay, chromosomal aberration assay, micronucleus test and the alkaline comet assay. WSF did not cause any mutation in the Ames assay using five tester strains at six concentrations of 0.16, 0.31, 0.63, 1.25, 2.5 and 5 ${\mu}l/plate$. To assess clastogenic effect, the in vitro chromosomal aberration assay was performed using Chinese hamster lung cells. No statistically significant increase in the number of metaphases with structural aberrations was observed at the concentrations of 1.25, 2.5, and 5 ${\mu}l/ml$. The in vitro comet assay and micronucleus test results obtained on L5178Y cells also revealed that WSF has no genotoxicity potential, although there was a marginal increase in micronuclei frequencies and DNA damage in the respective micronucleus and comet assays. Taken together, based on the results obtained from these four in vitro studies, it is concluded that WSF is not a mutagenic agent in bacterial cells and causes no chromosomal and DNA damage in mammalian cells in vitro.

• Toxicological Research
• /
• 제24권2호
• /
• pp.151-159
• /
• 2008

Rhus verniciflua Stokes(RVS), one of traditional medicinal plants in Asia, was found to have pharmacological activities such as antioxidative and antiapoptotic effects, raising the possibility for the development of a novel class of anti-cancer drugs. Thus, potential genotoxic effects of RVS in three short-term mutagenicity assays were investigated, which included the Ames assay, in vitro Chromosomal aberration test, and the in vivo Micronucleus assay. In Ames test, the addition of RVS water extracts at doses from 313 up to 5000 mg/plate induced an increase more than 2-fold over vehicle control in the number of revertant colonies in TA98 and TA1537 strains for detecting the frame-shift mutagens. The similar increase in reversion frequency was observed after the addition of RVS ethanol extracts. To assess clastogenic effect, in vitro chromosomal aberration test and in vivo micronucleus assay were performed using Chinese hamster lung cells and male ICR mice, respectively. Both water and ethanol extracts from RVS induced significant increases in the number of metaphases with structural aberrations mostly at concentrations showing the cell survival less than 60% as assessed by in vitro CA test. Also, there was a weak but statistically significant increase in number of micronucleated polychromatic erythrocytes(MNPCEs) in mice treated with water extract at 2000 mg/kg while ethanol extracts of RVS at doses of up to 2000 mg/kg did not induce any statistically significant changes in the incidence of MNPCEs. Therefore, our results lead to conclusion that RVS acts as a genotoxic material based on the available in vitro and in vivo results.

• Clinical and Experimental Reproductive Medicine
• /
• 제46권1호
• /
• pp.22-29
• /
• 2019

Objective: As paternal age increases, the quality of sperm decreases due to increased DNA fragmentation and aneuploidy. Higher levels of structural chromosomal aberrations in the gametes ultimately decrease both the morphologic quality of embryos and the pregnancy rate. In this study, we investigated whether paternal age affected the euploidy rate. Methods: This study was performed using the medical records of patients who underwent in vitro fertilization (IVF) procedures with preimplantation genetic screening (PGS) from January 2016 to August 2017 at a single center. Based on their morphological grade, embryos were categorized as good- or poor-quality blastocysts. The effects of paternal age were elucidated by adjusting for maternal age. Results: Among the 571 total blastocysts, 219 euploid blastocysts were analyzed by PGS (38.4%). When the study population was divided into four groups according to both maternal and paternal age, significant differences were only noted between groups that differed by maternal age (group 1 vs. 3, p= 0.031; group 2 vs. 4, p= 0.027). Further analysis revealed no significant differences in the euploidy rate among the groups according to the morphological grade of the embryos. Conclusion: Paternal age did not have a significant impact on euploidy rates when PGS was performed. An additional study with a larger sample size is needed to clarify the effects of advanced paternal age on IVF outcomes.

• 농약과학회지
• /
• 제8권1호
• /
• pp.22-29
• /
• 2004

제초제저항성단백질인 phosphinotricin acetyltransferase(PAT)에 대한 유전독성 영향을 평가하기 위하여 in vitro 시험으로 복귀돌연변이시험과 염색체이상시험을, 그리고 in vivo 시험으로 소핵시험을 수행하였다. Salmonella typhimurium 균주 TA98, TA100, TA1535 및 TA1537를 이용한 복귀돌연변이시험에서 직접법과 대사활성법 (S9 mixture) 모두 $5000{\mu}g/plate$에서 돌연변이 수는 음성대조군과 유의차가 없었다. Chinese hamster lung(CHL) 세포를 이용한 염색체이상시험 결과 직접법과 대사활성법의 경우 PAT를 처리한 모든 군(100, 10, $1{\mu}g/mL$) 의 세포에서 구조적, 숫적 염색체이상은 관찰되지 않았다. PAT를 복강 투여한 ICR계 숫컷 mouse의 골수세포에서 다염성 적혈구 (polychromatic erythrocytes) 및 소핵 (micronucleus)을 가진 다염성 적혈구의 출현율을 조사하기위하여 mouse를 이용한 소핵시험을 수행한 결과, 모든 농도(1250, 625, 313 mg/kg)에서 음성대조군과 유의차가 관찰되지 않아, PAT는 소핵을 유발하는 독성은 없는 것으로 판단된다. 이상의 결과로 제초제저항성단백질 PAT는 미생물, 배양세포, 및 생체내에서 유전독성을 유발하지 않는 물질로 사료된다.

• 한국식품위생안전성학회지
• /
• 제16권2호
• /
• pp.145-151
• /
• 2001

유아 식품중의 병마개 등에 약 30%까지 함유되어 합성수지 및 고무의 가소제로 많이 사용되고 있으나 최근 유럽등지에서 식품으로의 유리가 보고되어 안전성에 대한 재평가가 요구되어지고 있는 에폭시화 대두유 (Epoxidized soy bean oil, ESBO)의 유전독성을 평가하기 위해서 박테리아를 이용한 복귀돌연변이시험과 포유류 배양세포를 대상으로 검색하는 체외 염색체이상시험, 설치류의 조혈세포를 이용한 체내 소핵시험을 수행하였다. Salmonella typhimurium TA98, TA100, TA1535, TA1537, TA102균주를 이용한 복귀돌연변이 시험결과 직접법 및 대사활성화법에서 돌연변이 유발성을 가지지 않는 음성의 결과를 나타내었으며, chinese hamster lung cell을 이용한 염색체이상시험을 실시한 결과, 직접법 및 대사활성화법에서 염색체이상 유발작용을 보이지 않는 음성의 결과를 나타내었다. 또한 성별, 연령별에 따라서 마우스 골수세포를 이용한 소핵시험에서 에폭시화 대두유는 미성숙 적혈구중 유의성 있는 소핵 유발은 관찰되지 않았다. 이상의 결과를 종합하여, 본 시험조건 중 에폭시화 대두유는 in vitro 시험인 Salmonella 균주를 이용한 복귀돌연변이시험과 포유동물 배양세포를 이용한 염색체이상시험 및 in vivo 시험인 마우스를 이용한 소핵시험에서 유전독성을 유발하지 않는 것으로 판단된다.

• 농약과학회지
• /
• 제2권2호
• /
• pp.53-58
• /
• 1998

벼멸구에 대해 살충성이 있는 2-carbomethoxy-4-chlorodiethyl phosphate를 신농약으로 개발할 목적으로 변이원성 시험, 즉 유전자복귀돌연변이, 염색체이상 및 소핵시험을 수행하였다. Salmonella typhimurium을 이용한 복귀돌연변이원성을 TA1535, TA1537, TA98과 TA100 균주를 이용하여 시험한 결과 대사활성화물질(S-9mix)의 첨가여부에 관계없이 유전자에 이상을 미치지 않았으며, CHL세포에 대한 세포독성은 EMEM 배지에서 $LC_{50}$이 $200{\mu}g/m{\ell}$이었으므로 $200{\mu}g/m{\ell}$을 최고농도로 공비2, 농도4로 염색체이상시험을 실시한 결과 200과 $100{\mu}g/m{\ell}$에서 이상세포가 나타났으나 양성으로 판정되지는 않았다. 2-Carbomethoxy-4-chlorodiethyl phosphate가 ICR 마우스의 골수세포에 미치는 영향을 탐색하기 위해 실시한 소핵시험에서도 음성대조, 양성대조 및 시험물질처리 군에서 PCE 및 MNPCE의 출현율이 모두 정상범위 내에 있어서 2-carbomethoxy-4-chlorodiethyl phosphate가 ICR 마우스의 골수세포에 소핵을 형성시키지 않는 것이 확인되었다. 이상의 결과를 종합할 때 2-carbomethoxy-4-chlorodiethyl phosphate는 미생물, 배양세포 그리고 생체 내에서 유전물질에 영향을 주지 않는 물질인 것으로 판단된다.